| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |